TrialEBioMedicine2015

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer.

Jeanne Mendell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.